Novartis AG vs Under Armour Inc Class A — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Under Armour Inc Class A trades at $7.3 (market cap $3.07B). The key difference: Novartis AG is far larger — about 94.5× Under Armour Inc Class A's market cap, and Novartis AG pays a 3.17% dividend while Under Armour Inc Class A pays none. Which is the better fit depends on your goals.
| NVS | UAA | |
|---|---|---|
Market Cap | $290.25B | $3.07B |
Sector | Health | Consumer Cyclical |
52-Week High | $168.62 | $8.14 |
52-Week Low | $113.50 | $4.17 |
Enterprise Value | $330.27B | $4.70B |
Dividend Yield | 3.17% | — |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America and other territories. Consumers of its apparel include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through direct-to-consumer, including e-commerce and more than 400 combined factory house and brand house stores, and wholesale channels. Under Armour also operates a digital fitness app called MapMyFitness. The Baltimore-based company was founded in 1996.
Read more on UAA →